From Riyadh to Remission: Khalid's CAR-T Journey

The Diagnosis

At 42, Khalid was a successful entrepreneur in Riyadh when he was diagnosed with diffuse large B-cell lymphoma. After two rounds of chemotherapy failed to achieve remission, his oncologist in Saudi Arabia told him that conventional treatment options had been exhausted.

Finding MediPath China

Khalid's brother discovered MediPath China through a medical tourism conference in Dubai. Within 48 hours of submitting his case for review, Khalid received a detailed treatment plan from a team at one of China's leading hematology centers.

The Treatment

Khalid traveled to China for CAR-T cell therapy — a treatment that was available at a fraction of the US cost. The process took five weeks:

• Week 1: Comprehensive evaluation and T-cell collection
• Weeks 2-3: CAR-T cell manufacturing in the hospital's GMP lab
• Week 4: Lymphodepletion chemotherapy and CAR-T infusion
• Week 5: Monitoring for cytokine release syndrome

The Outcome

Three months after his CAR-T infusion, PET scans showed complete metabolic remission. Khalid has remained in remission for over 18 months and has returned to running his business.

Khalid's Words

"The medical care was extraordinary, but what surprised me most was how comfortable my family felt. The hospital had halal food, prayer facilities, and an Arabic-speaking coordinator who was with us every step of the way."